# Extra-pontine Myelinolysis After Rapid Correction of Hyponatremia Responding to Levodopa

**Authors:** Jagannath Dhadwad, Anish Chitnis

PMC · DOI: 10.7759/cureus.52707 · Cureus · 2024-01-22

## TL;DR

A patient developed extra-pontine myelinolysis after rapid correction of severe hyponatremia and showed improvement with levodopa treatment.

## Contribution

Demonstrates that levodopa may be effective in treating symptoms of extra-pontine myelinolysis.

## Key findings

- Rapid correction of hyponatremia led to extra-pontine myelinolysis with neurological symptoms.
- MRI showed hyperintensities in the caudate lobe consistent with EPM.
- Treatment with levodopa-carbidopa improved the patient's condition.

## Abstract

Osmotic demyelinating disease of the central nervous system has two variants: central pontine myelinolysis and extra-pontine myelinolysis (EPM). Up to 10% of cases of osmotic demyelination syndrome are associated with EPM, which mostly affects the thalamus and basal ganglia. It is commonly associated with the rapid correction of hyponatremia. An elderly woman in her 60s presented with complaints of acute gastroenteritis and giddiness and visited the emergency ward. On examination, she was conscious and oriented to time but disoriented to place and person and had slurring of speech with signs of dehydration. Her serum sodium levels were 100 meq/L, and her brain MRI was normal. After shifting her to the intensive care unit, she was treated with 200 ml of 3% NaCl bolus to correct her hyponatremia. On day three, she began developing rigidity in both lower limbs, which progressed to the upper limbs with hyperreflexia and mutism. A brain MRI was done, which showed subtle hyperintensities in the caudate lobe with no other new findings. Her serum aldosterone and cortisol were on the lower side of the normal range. Treatment of tablet levodopa-carbidopa (100/25) combination thrice a day (TDS) led to an improvement in her health condition.

## Linked entities

- **Chemicals:** levodopa (PubChem CID 6047), carbidopa (PubChem CID 34359), NaCl (PubChem CID 5234), aldosterone (PubChem CID 5839), cortisol (PubChem CID 5754)
- **Diseases:** gastroenteritis (MONDO:0002269)

## Full-text entities

- **Diseases:** gastroenteritis (MESH:D005759), Osmotic demyelinating disease of the central nervous system (MESH:D020278), mutism (MESH:D009155), Hyponatremia (MESH:D007010), EPM (MESH:D017590), rigidity (MESH:D009127), osmotic demyelination syndrome (MESH:D003711), dehydration (MESH:D003681), hyperreflexia (MESH:D012021)
- **Chemicals:** levodopa-carbidopa (MESH:C009265), cortisol (MESH:D006854), NaCl (MESH:D012965), sodium (MESH:D012964), Levodopa (MESH:D007980), aldosterone (MESH:D000450)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC10879730/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC10879730/full.md

## References

9 references — full list in the complete paper: https://tomesphere.com/paper/PMC10879730/full.md

---
Source: https://tomesphere.com/paper/PMC10879730